<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="27616">Psoralen</z:chebi> photochemotherapy (PUVA) was effective in the treatment of five patients with aquagenic <z:hpo ids='HP_0000989'>pruritus</z:hpo>, associated in one with <z:mp ids='MP_0002872'>polycythaemia</z:mp> rubra vera and in another with the <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Relapse occurred within 2-24 weeks when treatment was discontinued </plain></SENT>
<SENT sid="2" pm="."><plain>Maintenance therapy or a further course of PUVA was necessary to maintain remission </plain></SENT>
<SENT sid="3" pm="."><plain>This requirement may limit the value of the therapy </plain></SENT>
</text></document>